CVS Health names four new board members in deal with activist investor Glenview Capital
CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.
CVS Health, the parent company of Hartford health insurer Aetna, said Monday it has appointed four new members to its ...
CVS Health fell short on third-quarter profit, but it posted strong sales and shook up leadership under new CEO David Joyner ...
Michigan’s pension bought Palantir, Intel, and CVS Health stock, while slashing an investment in Bristol Myers in the third ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...
A vacant former CVS building in North Peoria is off the market. The property at 9315 N. Lindbergh Drive in Peoria was sold ...
Three prominent investment firms bet changes are in the offing at ailing healthcare giant CVS Health and added to existing ...
We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback